J Tataryn1, L Vrbova2, M Drebot3, H Wood3, E Payne4, S Connors2, J Geduld4, M German5, K Khan5,6, P A Buck7. 1. Centre for Food-borne, Environmental and Zoonotic Infectious Diseases (CFEZID), Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Saskatoon, SK. 2. Centre for Food-borne, Environmental and Zoonotic Infectious Diseases (CFEZID), Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Toronto, ON. 3. National Microbiology Laboratory, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Winnipeg, MB. 4. Office of Border and Travel Health, Health Security and Infrastructure Branch, Public Health Agency of Canada, Ottawa, ON. 5. Department of Medicine, Division of Infectious Diseases, University of Toronto, Toronto, ON. 6. Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON. 7. Centre for Food-borne, Environmental and Zoonotic Infectious Diseases (CFEZID), Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Ottawa, ON.
Abstract
BACKGROUND: Zika virus (ZIKV) is an emerging mosquito-borne disease that can cause severe birth defects if contracted congenitally. Since late 2015, there has been a large increase in the number of travel-related cases of Zika virus infection in Canada. OBJECTIVE: The objective of this study was to describe the epidemiology of travel-related Zika cases in Canada from October 2015 to June 2017 and review them in the context of the international outbreak in the Americas. METHODS: Zika virus infections were confirmed by polymerase chain reaction (PCR) detection of viral RNA and/or the serological identification of ZIKV-specific antibodies in serum. Cases of ZIKV infection were identified by provincial and territorial health authorities, and reported on a regular basis to the Public Health Agency of Canada (PHAC). Case information requested included date of illness onset, age category, sex, pregnancy status, and location(s) and dates of travel. Estimates for the monthly number of Canadians travelling outside of Canada to other countries in the Americas were obtained from Statistics Canada and the International Air Transport Association (IATA). Data to produce the epidemic curves of autochthonous cases for each region of the Americas were extracted from country-specific epidemic curves on the Pan American Health Organization website. RESULTS: As of June 7, 2017, 513 laboratory confirmed cases and two Zika-related birth/fetal anomalies were reported across all 10 provinces. Illness in Canadian travellers generally coincided with outbreak intensity in the country of exposure rather than travel volume. There has been no evidence of autochthonous (local) transmission in Canada. Currently, cases are on the decline both in Canada and internationally. CONCLUSION: The surge in Canadian ZIKV infections in 2016 was directly related to the incursion and spread of ZIKV into the Americas. Although cases are now on the decline worldwide, it remains to be seen whether a resurgence of cases in previously affected or new areas will occur. Both outbreak intensity and seasonality of ZIKV transmission should be monitored over time in order to inform the timing of public health education campaigns, as some may turn out to be more effective in the off-peak travel season when the risk of disease transmission may be higher. Ongoing education and awareness among travellers, particularly for pregnant women and those planning pregnancies, is still indicated.
BACKGROUND: Zika virus (ZIKV) is an emerging mosquito-borne disease that can cause severe birth defects if contracted congenitally. Since late 2015, there has been a large increase in the number of travel-related cases of Zika virus infection in Canada. OBJECTIVE: The objective of this study was to describe the epidemiology of travel-related Zika cases in Canada from October 2015 to June 2017 and review them in the context of the international outbreak in the Americas. METHODS: Zika virus infections were confirmed by polymerase chain reaction (PCR) detection of viral RNA and/or the serological identification of ZIKV-specific antibodies in serum. Cases of ZIKV infection were identified by provincial and territorial health authorities, and reported on a regular basis to the Public Health Agency of Canada (PHAC). Case information requested included date of illness onset, age category, sex, pregnancy status, and location(s) and dates of travel. Estimates for the monthly number of Canadians travelling outside of Canada to other countries in the Americas were obtained from Statistics Canada and the International Air Transport Association (IATA). Data to produce the epidemic curves of autochthonous cases for each region of the Americas were extracted from country-specific epidemic curves on the Pan American Health Organization website. RESULTS: As of June 7, 2017, 513 laboratory confirmed cases and two Zika-related birth/fetal anomalies were reported across all 10 provinces. Illness in Canadian travellers generally coincided with outbreak intensity in the country of exposure rather than travel volume. There has been no evidence of autochthonous (local) transmission in Canada. Currently, cases are on the decline both in Canada and internationally. CONCLUSION: The surge in Canadian ZIKV infections in 2016 was directly related to the incursion and spread of ZIKV into the Americas. Although cases are now on the decline worldwide, it remains to be seen whether a resurgence of cases in previously affected or new areas will occur. Both outbreak intensity and seasonality of ZIKV transmission should be monitored over time in order to inform the timing of public health education campaigns, as some may turn out to be more effective in the off-peak travel season when the risk of disease transmission may be higher. Ongoing education and awareness among travellers, particularly for pregnant women and those planning pregnancies, is still indicated.
Authors: Mark R Duffy; Tai-Ho Chen; W Thane Hancock; Ann M Powers; Jacob L Kool; Robert S Lanciotti; Moses Pretrick; Maria Marfel; Stacey Holzbauer; Christine Dubray; Laurent Guillaumot; Anne Griggs; Martin Bel; Amy J Lambert; Janeen Laven; Olga Kosoy; Amanda Panella; Brad J Biggerstaff; Marc Fischer; Edward B Hayes Journal: N Engl J Med Date: 2009-06-11 Impact factor: 91.245
Authors: Nicholas H Ogden; Aamir Fazil; David Safronetz; Michael A Drebot; Justine Wallace; Erin E Rees; Kristina Decock; Victoria Ng Journal: Parasit Vectors Date: 2017-01-25 Impact factor: 3.876
Authors: Carrie K Shapiro-Mendoza; Marion E Rice; Romeo R Galang; Anna C Fulton; Kelley VanMaldeghem; Miguel Valencia Prado; Esther Ellis; Magele Scott Anesi; Regina M Simeone; Emily E Petersen; Sascha R Ellington; Abbey M Jones; Tonya Williams; Sarah Reagan-Steiner; Janice Perez-Padilla; Carmen C Deseda; Andrew Beron; Aifili John Tufa; Asher Rosinger; Nicole M Roth; Caitlin Green; Stacey Martin; Camille Delgado Lopez; Leah deWilde; Mary Goodwin; H Pamela Pagano; Cara T Mai; Carolyn Gould; Sherif Zaki; Leishla Nieves Ferrer; Michelle S Davis; Eva Lathrop; Kara Polen; Janet D Cragan; Megan Reynolds; Kimberly B Newsome; Mariam Marcano Huertas; Julu Bhatangar; Alma Martinez Quiñones; John F Nahabedian; Laura Adams; Tyler M Sharp; W Thane Hancock; Sonja A Rasmussen; Cynthia A Moore; Denise J Jamieson; Jorge L Munoz-Jordan; Helentina Garstang; Afeke Kambui; Carolee Masao; Margaret A Honein; Dana Meaney-Delman Journal: MMWR Morb Mortal Wkly Rep Date: 2017-06-16 Impact factor: 17.586
Authors: Barry Atkinson; Fiona Thorburn; Christina Petridou; Daniel Bailey; Roger Hewson; Andrew J H Simpson; Timothy J G Brooks; Emma J Aarons Journal: Emerg Infect Dis Date: 2017-04-15 Impact factor: 6.883
Authors: Megan R Reynolds; Abbey M Jones; Emily E Petersen; Ellen H Lee; Marion E Rice; Andrea Bingham; Sascha R Ellington; Nicole Evert; Sarah Reagan-Steiner; Titilope Oduyebo; Catherine M Brown; Stacey Martin; Nina Ahmad; Julu Bhatnagar; Jennifer Macdonald; Carolyn Gould; Anne D Fine; Kara D Polen; Heather Lake-Burger; Christina L Hillard; Noemi Hall; Mahsa M Yazdy; Karnesha Slaughter; Jamie N Sommer; Alys Adamski; Meghan Raycraft; Shannon Fleck-Derderian; Jyoti Gupta; Kimberly Newsome; Madelyn Baez-Santiago; Sally Slavinski; Jennifer L White; Cynthia A Moore; Carrie K Shapiro-Mendoza; Lyle Petersen; Coleen Boyle; Denise J Jamieson; Dana Meaney-Delman; Margaret A Honein Journal: MMWR Morb Mortal Wkly Rep Date: 2017-04-07 Impact factor: 17.586